Page 10 - 91307c10 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Retirement Investment Advisors Inc. acquired a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,200 shares of the biotechnology company’s stock, valued at approximately $265,000. Other large investors […]

United Therapeutics (NASDAQ:UTHR – Get Free Report) and Tiziana Life Sciences (NASDAQ:TLSA – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends. Institutional & Insider Ownership 94.1% of United […]

Russell Investments Group Ltd. lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 12.4% in the second quarter, HoldingsChannel.com reports. The firm owned 116,338 shares of the biotechnology company’s stock after selling 16,450 shares during the period. Russell Investments Group Ltd.’s holdings in United Therapeutics were worth $25,682,000 as of […]

Rhumbline Advisers raised its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 5.2% during the second quarter, Holdings Channel.com reports. The firm owned 140,779 shares of the biotechnology company’s stock after purchasing an additional 6,997 shares during the quarter. Rhumbline Advisers’ holdings in United Therapeutics were worth $31,077,000 as of its most recent […]

United Therapeutics (NASDAQ:UTHR – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Thursday. Several other equities analysts also recently commented on UTHR. Morgan Stanley increased their target price on United Therapeutics from $316.00 to $318.00 and gave the […]